This inventor holds 4 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent. Top assignees: Cas Lamvac (Guangzhou) Biomedical Technology Co., Ltd., Bluelight Pharmatech Co., Ltd., Guangzhou Cas Lamvac Biotech Co., Ltd. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Guangdong, CN (2022)
- Guangzhou, CN (2022 - 2023)
Company Filing History:
2 out of 2 
1 out of 2 
1 out of 1 Years Active: 2022-2025
Title: Innovations and Contributions of Inventor Li Qin
Introduction
Li Qin is a notable inventor based in Guangzhou, China, recognized for his significant contributions to biomedical technology. With a total of four patents to his name, he has made strides in the field of medical research, particularly in the development of innovative therapies.
Latest Patents
Li Qin's latest patents include a chimeric antigen receptor and its application. This chimeric antigen receptor is designed to identify various components of the malarial protein VAR2CSA, which can bind to placental-like chondroitin sulfate A (pl-CSA). This innovation has the potential to target different types of tumor cells effectively. Another significant patent involves nanoparticle formulations of decoquinate, which utilizes hot-melt extrusion to create a solid solution that enhances the water solubility and bioavailability of decoquinate, improving its efficacy against malaria at the liver stage.
Career Highlights
Throughout his career, Li Qin has worked with prominent companies such as Cas Lamvac Biomedical Technology Co., Ltd. and Bluelight Pharmatech Co., Ltd. His work in these organizations has contributed to advancements in biomedical technologies and therapeutic solutions.
Collaborations
Li Qin has collaborated with notable colleagues, including Xiaoping Chen and Hongxing Wang, who have played essential roles in his research endeavors.
Conclusion
Li Qin's innovative work and patents reflect his commitment to advancing medical technology and improving treatment options for diseases such as malaria. His contributions are paving the way for future developments in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile